Esperion Therapeutics, Inc. (NASDAQ:ESPR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

One of the biggest stories of last week was how Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares plunged 21% in the… …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.